Video Gallery

Please see Dyadic’s YouTube Channel for more Videos

Dyadic (Nasdaq:DYAI) paves the way for patients to gain access to low-cost SARS-COV2 and other vaccines and drugs – March 31, 2020
Ping Rawson, CFO invited guest with MSQ Ventures - Fighting Virus Pandemics: The Now and The Future - Expert’s Perception of Challenges & Opportunities
February 27, 2020
Trish Regan Primetime. Fox Business - Dyadic International (Nasdaq:DYAI) CEO Mark Emalfarb discusses how his company could expedite the production of an affordable coronavirus vaccine.
Mark Emalfarb, CEO (Nasdaq:DYAI) on YAHOO Finance On The Move to discuss the spread of Coronavirus February 4, 2020
Mark Emalfarb / TD Ameritrade Interview “The Watch List” February 11, 2020
#TradeTalks: Getting Ahead of the Curve on Pandemic & Biological Threats with Synthetic Biology February 2020
Dyadic Getting Ahead of the Curve on Coronavirus Cure, CEO Says January 31, 2020
Dyadic CEO Mark Emalfarb interviewed by Liz Claman “The Claman Countdown” from FOX Business Network - Monday, January 27, 2020
Dyadic CEO remarks on steps the federal gov't can take to speed along drug manufacturing January 2020
Dyadic International reveals recent 4Q highlights and upcoming milestones January 2020
Dyadic International, Inc. (OTCQX: DYAI) The Innovation Show – August 2017 | From Stonewashed Jeans to Lifesaving Genes
Dyadic Seeks to Bring Disruptive Technology to Biomanufacturing, The Bio Report, June 2017